Back to UBS Group AG UBS Group AG

BMRNBMRN
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in BIOMARIN PHARMACEUTICAL INC

UBS Group AG holds 1.3M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $73.6M as of 2026-Q2. The position was decreased (-14.1% shares). BMRN represents 0.0% of UBS Group AG's portfolio.

Current Value

$73.6M

Current Shares

1.3M

Total Value Change

+$13M

Total Shares Change

+424,534

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.3M
-14.1%
$73.6M0.0%$57.22
0
2026-Q1
Decreased
1.5M
-32.3%
$84.6M0.0%$56.49
0
2025-Q4
Increased
2.2M
+43.6%
$131.4M0.0%$59.43
41
2025-Q3
Decreased
1.5M
-9.2%
$83.4M0.0%$54.16
0
2025-Q2
Increased
1.7M
+0.1%
$93.2M0.0%$54.97
30
2025-Q1
Increased
1.7M
+12.3%
$119.7M0.0%$70.69
34
2024-Q4
Increased
1.5M
+75.0%
$99.2M0.0%$65.73
45
2024-Q3
Increased
861,971
+123.6%
$60.6M0.0%$70.29
48

Other major holders of BMRN: BNP PARIBAS FINANCIAL MARKETS, Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used